A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV

NCT06642584 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers Type 2 Diabetes

Interventions

DRUG: Semaglutide B
DRUG: Semaglutide J
DRUG: Semaglutide L
DRUG: Semaglutide M
DRUG: Semaglutide N

Sponsor

Novo Nordisk A/S